USE OF 2'-DEOXY-4'-THIOCYTIDINE AND ITS ANALOGUES AS DNA HYPOMETHYLATING ANTICANCER AGENTS
Compounds represented by the formulae: wherein R is individually selected from the group consisting of H, aliphatic acyl, aromatic acyl group, fluoro, chloro, bromo, iodo, alkoxy, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, amino, monoalkylamino, dialkylamino, cyano, aryl and nitro; pharmaceutically acceptable salts thereof, prodrugs thereof, solvates thereof and mixtures thereof; are used as inhibitors of DNA methyltransferase and for treating patients suffering from diseases resulting from or related to aberrant DNA methylation such as myelodysplastic syndromes and other cancers.
1 . A method for inhibiting DNA methyltransferase in cells of a patient by administering to the patient at least one compound represented by the formulae:
wherein R is individually selected from the group consisting of H, aliphatic acyl, aromatic acyl, halo, alkoxy, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, amino, monoalkylamino, dialkylamino, cyano, aryl and nitro; a pharmaceutically acceptable salt thereof, a prodrug thereof, a solvate thereof or mixtures thereof.
2 . The method of claim 1 wherein said at least one compound comprises a compound represented by the formula:
3 . The method of claim 2 wherein R is hydrogen.
4 . The method of claim 1 wherein said at least one compound comprises a compound represented by the formula:
5 . The method of claim 1 wherein said at least one compound comprises a compound represented by the formula:
6 . The method of claim 1 wherein the patient is afflicted with myeloid dysplastic syndromes or other myeloid malignancies.
7 . The method of claim 6 wherein said at least one compound comprises a compound represented by the formula:
8 . The method of claim 7 wherein R is hydrogen.
9 . The method of claim 6 wherein said at least one compound comprises a compound represented by the formula:
10 . The method of claim 6 wherein said at least one compound comprises a compound represented by the formula:
11 . A method for treating a patient afflicted with cancers or diseases resulting from or related to aberrant DNA methylation which comprises administering to said patient an effective amount of at least one compound represented by the formula:
wherein R is individually selected from the group consisting of H, aliphatic acyl, aromatic acyl, halo, alkoxy, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, amino, monoalkylamino, dialkylamino, cyano, aryl and nitro; a pharmaceutically acceptable salt thereof, a prodrug thereof, a solvate thereof and mixtures thereof.
12 . The method of claim 11 wherein said at least one compound comprises a compound represented by the formula:
13 . The method of claim 12 wherein R is hydrogen.
14 . The method of claim 11 wherein said at least one compound comprises a compound represented by the formula:
15 . The method of claim 11 wherein said at least one compound comprises a compound represented by the formula: